Insider · CIK 0001859509
Looker Benjamin
Reports to the SEC for 2 companies · ANN ARBOR, MI
Transactions
27
Companies
2
Filings
14
CIK
0001859509
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-07-13 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-07-13 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-07-13 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-07-13 | ESPREsperion Therapeutics, Inc.D Disposition to Issuer | — |
| 2026-06-17 | ESPREsperion Therapeutics, Inc.S Sale | −$37.3K |
| 2026-03-17 | ESPREsperion Therapeutics, Inc.S Sale | −$15.4K |
| 2026-03-13 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-03-13 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2026-01-20 | ESPREsperion Therapeutics, Inc.S Sale | −$4,867.698 |
| 2025-12-17 | ESPREsperion Therapeutics, Inc.S Sale | −$23.9K |
| 2025-10-17 | ESPREsperion Therapeutics, Inc.S Sale | −$3,275.376 |
| 2025-09-17 | ESPREsperion Therapeutics, Inc.S Sale | −$17.6K |
| 2025-07-17 | ESPREsperion Therapeutics, Inc.S Sale | −$1,469.608 |
| 2025-06-17 | ESPREsperion Therapeutics, Inc.S Sale | −$7,398.144 |
| 2025-03-14 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-03-14 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2024-03-14 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2024-03-14 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2023-04-19 | ESPREsperion Therapeutics, Inc.S Sale | −$1,640.88 |
| 2023-03-14 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2023-03-14 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2023-01-18 | ESPREsperion Therapeutics, Inc.S Sale | −$44.4K |
| 2022-06-07 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-01-27 | ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-01-27 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2021-11-17 | Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2021-05-03 | Trillium Therapeutics Inc.Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Looker Benjamin0001628280-26-048001SEC(opens sec.gov)
- 4Looker Benjamin0001628280-26-044269SEC(opens sec.gov)
- 4Looker Benjamin0001628280-26-019413SEC(opens sec.gov)
- 4Looker Benjamin0001628280-26-018194SEC(opens sec.gov)
- 4Looker Benjamin0001628280-26-002925SEC(opens sec.gov)
- 4Looker Benjamin0001628280-25-057941SEC(opens sec.gov)
- 4Looker Benjamin0001628280-25-045520SEC(opens sec.gov)
- 4Looker Benjamin0001859509-25-000004SEC(opens sec.gov)
- 4Looker Benjamin0001628280-25-035336SEC(opens sec.gov)
- 4Looker Benjamin0001628280-25-032219SEC(opens sec.gov)
- 4Looker Benjamin0001628280-25-013195SEC(opens sec.gov)
- 4Looker Benjamin0001628280-24-011490SEC(opens sec.gov)
- 4Looker Benjamin0001628280-23-012264SEC(opens sec.gov)
- 4Looker Benjamin0001628280-23-007971SEC(opens sec.gov)
Companies
Address
C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150
ANN ARBOR, MI, 48108